SLC5A2 and diabetes mellitus: In pathological states such as diabetes mellitus, where SGLT2 inhibitors are therapeutically employed to induce glycosuria and lower plasma glucose levels, the role of SGLTs in glucose homeostasis is especially highlighted [11,12].